Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aclidinium bromide/formoterol pharmacokinetics in Chinese COPD patients
CTR20170706Phase 2Completed
- Sponsor
- Almirall
- Start
- May 2018
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of aclidinium bromide + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Almirall. Started May 2018; status: completed.
02
Drugs
aclidinium bromide + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20170706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170706.